For anyone facing cancer, the treatment options can feel brutally familiar: surgery, radiotherapy, chemotherapy, or a combination of them all. But a new approach is beginning to offer something very ...
HistoSonics, a company founded by biomedical engineer Zhen Xu in 2009, is developing a technique called histotripsy to target ...
Phase 3 lidERA evaluates daily oral SERD giredestrant in ER+/HER2- early disease, including subgroup analyses by age and menopausal status after a reported 30% risk reduction. Primary ASCENT-04 data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results